Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atezolizumab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT06099418
What this trial is testing

Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.

Who this might be right for
HPV-Related Cervical CarcinomaHPV-Related MalignancyCervical Cancer
Nykode Therapeutics ASA
Large-scale testing (Phase 3)Study completedNCT04619797
What this trial is testing

Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Hoffmann-La Roche 542
Testing effectiveness (Phase 2)Active Not RecruitingNCT05968326
What this trial is testing

The Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC

Who this might be right for
Adenocarcinoma, Pancreatic Ductal
Genentech, Inc. 260
Early research (Phase 1)Study completedNCT02508870
What this trial is testing

Atezolizumab Administered Alone or in Combination With Azacitidine in Participants With Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
Hoffmann-La Roche 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT05681039
What this trial is testing

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

Who this might be right for
Squamous Cell CarcinomaOral Cavity Squamous Cell Carcinoma
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Looking for participantsNCT06793553
What this trial is testing

Induction Therapy of PTX+BV Followed by Atezolizumab+Nab-PTX for PD-L1+ TNBC

Who this might be right for
Metastatic Breast Cancer
Japan Breast Cancer Research Group 106
Post-approval studies (Phase 4)Looking for participantsNCT05185505
What this trial is testing

Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria

Who this might be right for
Hepatocellular CarcinomaHepatocellular Cancer
The Methodist Hospital Research Institute 24
Not applicableLooking for participantsNCT07279402
What this trial is testing

TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%

Who this might be right for
NSCLC Stage IVPD-L1 Gene MutationAtezolizumab+1 more
Antalya Training and Research Hospital 150
Early research (Phase 1)Ended earlyNCT04167137
What this trial is testing

Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants

Who this might be right for
Metastatic Solid NeoplasmLymphoma
Synlogic 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT04186013
What this trial is testing

Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer

Who this might be right for
Bladder Cancer
Spanish Oncology Genito-Urinary Group 39
Testing effectiveness (Phase 2)Ended earlyNCT02982694
What this trial is testing

Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer

Who this might be right for
MSIColoRectal CancerChemotherapy+1 more
Vall d'Hebron Institute of Oncology 46
Testing effectiveness (Phase 2)Looking for participantsNCT07239245
What this trial is testing

Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo

Who this might be right for
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Not applicableLooking for participantsNCT06961526
What this trial is testing

Esophageal Varices Prophylaxis in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab

Who this might be right for
Esophageal and/or Gastric VaricesHepatocellular Carcinoma (HCC)
Tanta University 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT01898117
What this trial is testing

Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 304
Testing effectiveness (Phase 2)Active Not RecruitingNCT03202316
What this trial is testing

Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer

Who this might be right for
Recurrent Breast Inflammatory CarcinomaStage IV Breast Inflammatory Carcinoma
M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT03464942
What this trial is testing

Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Peter MacCallum Cancer Centre, Australia 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT03237780
What this trial is testing

Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer

Who this might be right for
Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+21 more
National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)Looking for participantsNCT06133062
What this trial is testing

Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Chang Gung Memorial Hospital 45
Testing effectiveness (Phase 2)Ended earlyNCT05315713
What this trial is testing

An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Combination With Tiragolumab With or Without Atezolizumab in Participants With B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma, Follicular Lymphoma
Hoffmann-La Roche 8
Testing effectiveness (Phase 2)Study completedNCT02994576
What this trial is testing

Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 60
Next Page